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Abstract
Poisson-Boltzmann (PB) model is one of the most popular implicit solvent models in bio-
physical modeling and computation. The ability of providing accurate and reliable PB estima-
tion of electrostatic solvation free energy, ∆Gel, and binding free energy, ∆∆Gel, is important
to computational biophysics and biochemistry. Recently, it has been warned in the literature
(Journal of Chemical Theory and Computation 2013, 9, 3677-3685) that the widely used grid
spacing of 0.5Å produces unacceptable errors in ∆∆Gel estimation with the solvent exclude
surface (SES). In this work, we investigate the grid dependence of our PB solver (MIBPB)
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with SESs for estimating both electrostatic solvation free energies and electrostatic binding
free energies. It is found that the relative absolute error of ∆Gel obtained at the grid spacing of
1.0Å compared to ∆Gel at 0.2Å averaged over 153 molecules is less than 0.2%. Our results
indicate that the use of grid spacing 0.6Å ensures accuracy and reliability in ∆∆Gel calcula-
tion. In fact, the grid spacing of 1.1Å appears to deliver adequate accuracy for high throughput
screening.
1 Introduction
Electrostatics is ubiquitous in biomolecular and cellular systems and of paramount importance to
biological processes. Accurate and reliable prediction of electrostatic binding free energy, ∆∆Gel,
is crucial to biophysical modeling and computation. The prediction of ∆∆Gel plays a vital role
in the study of many cellular processes, such as signal transduction, gene expression, and protein
synthesis. Additionally, many pharmaceutical applications, specially in the final stage of the drug
design, rely on the accurate and reliable calculation of binding free energy. Technically, the accu-
racy and reliability of electrostatic binding energy prediction depend essentially on the quality of
electrostatic solvation (∆Gel) estimation, which can be achieved by solving the Poisson-Boltzmann
(PB) equation in the implicit solvent model.1–5 In past decades, the development of a robust PB
solver catches much attention in computational biophysics and biochemistry. Mathematically, most
PB solvers reported in the literature are based on three major approaches, namely, the finite dif-
ference method (FDM),6 the finite element method (FEM),7 and the boundary element method
(BEM).8,9 Among them, the FDM is prevalently used in the field due to its simplicity in imple-
mentation. The emblematic solvers in this category are Amber PBSA,10,11 Delphi,12,13 APBS14
and CHARMM PBEQ.6
Recently, it has been warned that “the widely used grid spacing of 0.5 Å produces unacceptable
errors in ∆∆Gel”.15 Although all results were obtained with the adaptive Cartesian grid (ACG)
finite difference PB equation solver16 in this work, similar results were reported in a later study17
by using APBS, DelPhi and PBSA. Therefore, these studies have arisen serious concerns about
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the validity of using PB model for biomolecular electrostatic binding analysis at an affordable grid
spacing of 0.5 Å.
In the past few years, there have been many attempts to develop highly accurate PB solvers
using advance techniques for interface treatments.16,18–20 The later verison of the ACG solver16,18
has somewhat remedied the grid-dependence issue for estimates of binding energy. However, no
confirmation for the reliable use of grid spacing of 0.5 Å in ∆∆Gel has been given. In this work,
we investigate the grid dependence of our PB solver (MIBPB)21,22 in estimating both electrostatic
solvation free energies and electrostatic binding free energies. The MIBPB solver is by far the only
existing method that is second-order accurate in L∞ norm for solving the Poisson-Boltzmann equa-
tion with discontinuous dielectric constants, singular charge sources, and geometric singularities
from the solvent excluded surfaces (SESs) of biomolecules.21 Here the L∞ norm means the max-
mum absolute error measure and “second order accurate” means that the error reduces four times
when the grid spacing is halved. Contrary to the findings in the literature,15 our results indicate
that the use of grid spacing 0.6 Å ensures accuracy and reliability in ∆∆Gel calculation. In fact,
a grid spacing of 1.1 Å appears to deliver adequate accuracy for high throughput screening. We
therefore believe that when it is used properly, the PB methodology is able to deliver accurate and
reliable electrostatic binding analysis.
2 Methods
2.1 MIBPB package
In the current work, we employ the our MIBPB package21,22 to predict the electrostatic solvation
free energy. The MIBPB package is a second-order convergence PB solver for dealing with the
SESs of biomolecules. Numerically, there are three major obstacles in constructing accurate and
reliable PB solvers. First, commonly used solvent-solute interfaces, i.e., the van der Walls (vdW)
surface, solvent accessible surface (SAS), and the solvent excluded surface (SES)23,24 admit ge-
ometric singularities, such as sharp tips, cusps and self-intersecting surfaces,25 which make the
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rigorous enforcement of interface jump conditions a formidable task in PB solvers. An advanced
mathematical interface techniques, the matched interface and boundary (MIB) method,26–31 is
employed in the MIBPB package to achieve the second order accuracy in handling biomolecu-
lar SESs. Additionally, the atomic singular charges described by the delta functions give rise to
another difficulty in constructing highly accurate PB solver. A Dirichlet-to-Neumann map tech-
nique has been developed in the MIBPB package to avoid the numerical approximation of singular
charges by using the analytical Green’s functions.32 Finally, the nonlinear Boltzmann term can
affect solver efficiency when handled inappropriately, particularly for BEMs. A quasi-Newton
algorithm is implemented in the MIBPB package21,22 to take care the nonlinear term.21,22
2.2 Interface generation
Many studies suggest that SES is able to deliver the state of the art accurate modeling of the sol-
vated molecule.7,9,13 As a result, much effort has been paid to developing an accurate and robust
SES software.25,33 However, the MSMS software25 generates a Lagrangian representation of the
SES and is inconvenient for the Cartesian domain implementation of PB solvers. A Lagrangian
to Eulerian transformation is required to convert MSMS surfaces for our Cartesian based MIBPB
solver.4 Most recently, we have developed a new SES software, Eulerian solvent excluded sur-
face (ESES), to directly generate the SESs in the Eulerian representation.34 Our ESES software
enables the MIBPB solver to produce a reliable ∆Gel. Both MSMS and ESES are supported by
our MIBPB software. By increasing the MSMS surface density, the electrostatic solvation free
energies calculated by using MSMS converge to those obtained by using ESES.34 Therefore, only
results employing ESES are shown in this work.
2.3 Data sets
In the present work, we adopt three sets of biomolecular complexes employed in the literature15
for solvation free energy and binding free energy estimations. Specifically, the first set, Data
Set 1, is a collection of DNA-minor groove drug complexes having a narrow range of ∆∆G.
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The Protein Data Bank (PDB) IDs (PDBIDs) for this set are as follows: 102d, 109d, 121d,
127d, 129d, 166d, 195d, 1d30, 1d63, 1d64, 1d86, 1dne, 1eel, 1fmq, 1fms, 1jtl, 1lex, 1prp,
227d, 261d, 164d, 289d, 298d, 2dbe, 302d, 311d, 328d, and 360d. The second set, Data Set
2, includes various wild-type and mutant barnase-barstar complexes. Its PDBIDs are as fol-
lows: 1b27, 1b2s, 1b2u, 1b3s, 2aza4, 1x1w, 1x1y, 1x1u, and 1x1x. In the last set, Data Set 3,
we investigate RNA-peptide complexes with following PDBIDs: 1a1t, 1a4t, 1biv, 1exy, 1g70,
1hji, 1i9f, 1mnb, 1nyb, 1qfq, 1ull, 1zbn, 2a9x, and 484d. The detail of the structural prepos-
sessing can be found in Ref. Harris et al.. The data sets can be downloaded from website
http://www.sb.fsu.edu/˜mfenley/convergence/downloads/convergence_pqr_sets.tar.gz. They are also
available from the present authors upon request.
2.4 Poisson-Boltzmann calculation details
The electrostatics binding free energy is a measure of binding affinity of two compounds due to
the electrostatics interaction. Based on the free energy cycle, the electrostatics binding free energy
can be calculated by the following formula35
∆∆Gel = (∆Gel)AB− (∆Gel)A− (∆Gel)B +(∆∆Gel)Coulomb , (1)
where (∆Gel)AB is the electrostatic solvation free energy of the bounded complex AB, (∆Gel)A and
(∆Gel)B are the electrostatic solvation free energies of the unbounded components A and B, and
(∆∆Gel)Coulomb is the electrostatic binding free energy of the two components in vacuum.
The electrostatic solvation free energies ∆Gel are obtained by using MIBPB software21,22 while
the binding energy (∆∆Gel)Coulomb is easily evaluated analytically via the following formula
(∆∆Gel)Coulomb =∑
i, j
qiq j
εmri j
, ∀i ∈ A, j ∈ B, (2)
where qi and q j are the corresponding charges of the given pair of atoms, and ri j is the distance be-
tween this pair. Here, εm is the dielectric constant of the solute region. Table S3 (in the supporting
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(a) PDBID: 121d
(b) PDBID: 1b3s (c) PDBID: 1biv
Figure 1: Illustration of surface electrostatic potentials (in units of kcal/mol/e) for three complexes,
generated by Chimera software.36 (a) PDBID: 121d (in Drug-DNA complexes); (b) PDBID: 1b3s
(in barnase-barstar complexes); (c) PDBID: 1biv (in RNA-peptide complexes).
information) lists (∆∆Gel)Coulomb values of 51 studied complexes.
In all our calculations, the absolute temperature of the ionic solvent is chosen to be T = 298 K,
the dielectric constants for solute and solvent are 1 and 80, and the ionic strength is 0.1 M NaCl.
The PBE is solved by the linearized solver, but the nonlinear one does not produce any notably
differences. The incomplete LU biconjugate gradient squared (ILUBGS) solver is employed to
solve all linear systems risen by the MIBPB approach. To maintain consistent computations of
the PB solver at different grid sizes, the criteria convergence of ILUBGS solver measured by L2-
norm is set to be 10−6, and the maximum iteration number is set to 100,000. The predictions of
MIBPB solver on ∆Gel and ∆∆Gel are confirmed by other solvers such as PBSA,10,11 Delphi,12,13
and APBS14 at the grid size of 0.2 Å, see Table S2 of Supporting Information.
3 Results and discussion
As described above, we consider three sets of binding complexes, namely, drug-DNA, barnase-
barstar and RNA-peptide systems. For the sake of illustration, three sample surface electrostatic
potentials, each from one distinct set, are depicted in Fig. 1. PDBIDs for these three complexes
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Table 1: R2 values and best fitting lines of electrostatic solvation free energies with different grid
sizes.
Grid sizes (pair) R2 Best fitting line
DNA-drug (0.2,0.3) 1.0000 y= 1.0000x−0.0196
(0.2,0.4) 1.0000 y= 1.0000x−0.0081
(0.2,0.5) 1.0000 y= 1.0001x−0.0621
(0.2,0.6) 1.0000 y= 1.0001x−0.2230
(0.2,0.7) 1.0000 y= 1.0003x−0.2537
(0.2,0.8) 1.0000 y= 1.0003x−0.4161
(0.2,0.9) 1.0000 y= 1.0003x−0.2999
(0.2,1.0) 1.0000 y= 1.0005x−0.0066
(0.2,1.1) 1.0000 y= 1.0004x−0.2485
Barnase-barstar (0.2,0.3) 1.0000 y= 1.0002x+0.1590
(0.2,0.4) 1.0000 y= 1.0005x+0.3524
(0.2,0.5) 1.0000 y= 1.0012x+0.8735
(0.2,0.6) 1.0000 y= 1.0010x−0.2246
(0.2,0.7) 1.0000 y= 1.0017x−0.3748
(0.2,0.8) 1.0000 y= 1.0009x−0.9576
(0.2,0.9) 0.9999 y= 1.0015x+0.4749
(0.2,1.0) 0.9999 y= 0.9986x−2.9739
(0.2,1.1) 0.9997 y= 0.9972x−4.3801
RNA-peptide (0.2,0.3) 1.0000 y= 1.0000x−0.0445
(0.2,0.4) 1.0000 y= 1.0000x−0.1333
(0.2,0.5) 1.0000 y= 1.0000x−0.3343
(0.2,0.6) 1.0000 y= 1.0000x−0.1916
(0.2,0.7) 1.0000 y= 1.0001x−0.5377
(0.2,0.8) 1.0000 y= 1.0001x−0.8198
(0.2,0.9) 1.0000 y= 1.0002x−0.9564
(0.2,1.0) 1.0000 y= 1.0003x−0.8868
(0.2,1.1) 1.0000 y= 1.0005x−2.2504
are respectively 121d (in Drug-DNA complexes), 1b3s (in barnase-barstar complexes), and 1biv
(in RNA-peptide complexes). In the rest of this section, we explore the influence of grid spacing
in Poisson-Boltzmann equation solvation and binding free energy estimations using our MIBPB
solver.
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Figure 2: Electrostatic solvation free energy, for all complexes and unbounded components of
three data sets, with different grid sizes plotted against the one computed with a finest grid size
of h = 0.2Å. (a) DNA-drug with pair (0.2Å,0.3Å); (b) DNA-drug with pair (0.2Å,0.7Å); (c)
DNA-drug with pair (0.2Å,1.1Å); (d) Barnase-barstar with pair (0.2Å,0.3Å); (e) Barnase-barstar
with pair (0.2Å,0.7Å); (f) Barnase-Barstar with pair (0.2Å,1.1Å); (g) RNA-peptide with pair
(0.2Å,0.3Å); (h) RNA-peptide with pair (0.2Å,0.7Å); (i) RNA-peptide with pair (0.2Å,1.1Å).
3.1 The influence of grid spacing in ∆Gel estimation
We first examine the accuracy and robustness of our MIBPB solver in predicting the electrostatic
solvation free energies of the aforementioned three data sets. Some previous literature37,38 has
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Figure 3: Averaged relative absolute error of the electrostatic solvation free energies for all the 153
molecules with mesh size refinements from 1.1Å to 0.2Å.
recognized that a grid size of h = 0.5Å is small enough to produce a reliable ∆Gel. Such an
observation certainly remains for the MIBPB solver. In fact, our PB solver is able to deliver a very
well-convergent calculations of electrostatic solvation free energies at as coarse grid sizes as 1.0Å
and 1.1Å.
In the current calculations, the finest grid size is chosen to be 0.2Å, and the coarser grid sizes
are between 0.3Å and 1.1Å. Figure 2 depicts the correlations of ∆Gel at various meshes for all
complexes and unbounded components of three data sets. The electrostatic solvation free ener-
gies obtained at the finest grid spacing of 0.2Å are plotted against those computed from coarser
grid spacings of 0.3Å, 0.7Å and 1.1Å. Obviously, the best fitting lines for these data at var-
ious coarse grid spacings produce near perfect alignments between the finest mesh results and
those from coarse meshes. As shown in Table 1, R2 and slope values at the pair of grid sizes
(0.2Å,1.1Å) for DNA-drug, barnase-barstar and RNA-peptide are, respectively, (1.0000,1.0004),
(0.9997,0.9972), and (1.0000,1.0005). These results indicate the accuracy and robustness in the
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MIBPB prediction of electrostatic solvation free energies (∆Gel). Table S1, in the Supporting In-
formation, reports the values ∆Gel for all the 51 complexes and associated 102 components studied
in this work. Finally, we examine the performance of our solver by considering the relative abso-
lute error, the difference between results obtained with coarser and the finest grid spacings, defined
as follows
Relative absolute error .=
∣∣∣∣∆Gel,h−∆Gel,h=0.2∆Gel,h=0.2
∣∣∣∣ . (3)
Figure 3 illustrates the averaged relative absolute errors, i.e., the average of relative absolute
errors designated in Eq. (??) over all the 153 discussed molecules, at different mesh sizes. It can be
seen from Fig. 3 that the averaged relative absolute errors at all studied cases are less than 0.31%,
and for any grid spacing smaller than 1.1Å, these errors are always below 0.2%. This behavior
further indicates the grid size independence of our PB solver over the normal grid-size range in
molecular biophysical applications.
3.2 The influence of grid spacing in ∆∆Gel estimation
Motivated by well-converged estimations of electrostatic solvation free energies at very coarse grid
spacings as previously discussed, we are interested in predicting the binding free energies for all
RNA-drug, barnase-barstar, and RNA-peptide complexes using our MIBPB package.
Similar to the study of the convergence of ∆Gel, we correlate the binding free energy calculated
at the finest grid spacing, h= 0.2Å, and ones estimated at coarser mesh sizes, h= 0.3Å, · · · ,1.1Å.
Figure 4 illustrates these relationships with the regression lines whose parameters are revealed in
Table 2. Since the previous discussion confirms MIBPB solver can produce very good R-squared
values even at very coarse grid spacings, it is interesting to explore whether a similar behavior can
be found for binding energy estimation. Indeed, the PB binding energy estimation behaves the
same as the PB solvation calculation in our MIBPB technique. Specifically, R2 is always 1 at the
fine mesh, h= 0.3Å. Moreover, these values are still satisfactory at relatively coarser mesh sizes.
For example, at the grid spacing of h= 1.1, the R2 and slope of the regression line for DNA-drug,
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Figure 4: Electrostatic binding free energy, for all complexes with different grid sizes plotted
against the one computed with a finest grid size of h= 0.2Å. (a) DNA-drug with pair (0.2Å,0.3Å);
(b) DNA-drug with pair (0.2Å,0.7Å); (c) DNA-drug with pair (0.2Å,1.1Å); (d) Barnase-barstar
with pair (0.2Å,0.3Å); (e) Barnase-barstar with pair (0.2Å,0.7Å); (f) Barnase-barstar with pair
(0.2Å,1.1Å); (g) RNA-peptide with pair (0.2Å,0.3Å); (h) RNA-peptide with pair (0.2Å,0.7Å);
(i) RNA-peptide with pair (0.2Å,1.1Å).
barnase-barstar, and RNA-peptide complexes are, respectively, (0.9747,1.0081), (0.8002,0.8187),
and (0.9998, 0.9937). In contrast, the R-squared values reported in Ref.,15 computed between
0.3Å and 1.0Å, are unacceptable for SESs, and usually less than 0.62. Our statistical measures
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Table 2: R2 values and best fitting lines of electrostatic binding free energies with different grid
sizes.
Grid sizes (pair) R2 Best fitting line
DNA-drug (0.2,0.3) 1.0000 y= 0.9993x+0.0194
(0.2,0.4) 0.9999 y= 0.9987x+0.0273
(0.2,0.5) 0.9998 y= 1.0028x+0.0164
(0.2,0.6) 0.9991 y= 1.0047x+0.2256
(0.2,0.7) 0.9982 y= 1.0074x+0.1394
(0.2,0.8) 0.9966 y= 1.0110x+0.1484
(0.2,0.9) 0.9906 y= 0.9655x+1.2385
(0.2,1.0) 0.9875 y= 0.9827x+0.5894
(0.2,1.1) 0.9747 y= 1.0081x+0.0709
Barnase-barstar (0.2,0.3) 0.9999 y= 0.9974x+0.2035
(0.2,0.4) 0.9995 y= 0.9997x−0.0492
(0.2,0.5) 0.9923 y= 1.0318x−2.7755
(0.2,0.6) 0.9946 y= 0.9878x+1.5525
(0.2,0.7) 0.9932 y= 1.0090x+0.1819
(0.2,0.8) 0.9883 y= 0.9766x+3.7333
(0.2,0.9) 0.9493 y= 0.9382x+5.3970
(0.2,1.0) 0.9384 y= 1.0912x−3.8377
(0.2,1.1) 0.8002 y= 0.8187x+18.2837
RNA-peptide (0.2,0.3) 1.0000 y= 0.9997x−0.0655
(0.2,0.4) 1.0000 y= 1.0001x−0.1106
(0.2,0.5) 1.0000 y= 1.0012x−0.2755
(0.2,0.6) 1.0000 y= 0.9999x+0.2021
(0.2,0.7) 0.9999 y= 1.0037x−0.3756
(0.2,0.8) 1.0000 y= 1.0004x+0.6673
(0.2,0.9) 0.9999 y= 0.9927x+1.9755
(0.2,1.0) 0.9997 y= 0.9923x+2.8775
(0.2,1.1) 0.9998 y= 0.9937x+1.7992
strongly support the reliable binding energy prediction of our solver at coarse grid sizes. Table 3
displays the binding free energy for all complexes with different grid spacings. As can be seen from
Table 3, the difference between binding energies at coarse meshes and the finest mesh, h= 0.2Å,
is mostly less than 10 kcal/mol for all complexes.
The trend of binding free energy at different grid spacings can be seen clearly in Figs. 5 which
plots ∆∆Gel against grid sizes varying between 0.2Å and 1.1Å for DNA-drug complexes. Similar
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Table 3: Electrostatic binding free energies (in units of kcal/mol), ∆∆Gel, for all of the
complexes used in this study at different grid sizes.
complexes 1.1Å 1.0Å 0.9Å 0.8Å 0.7Å 0.6Å 0.5Å 0.4Å 0.3Å 0.2Å
DNA-drug 102d 9.45 10.50 8.73 10.01 10.21 10.76 10.53 10.45 10.34 10.31
109d 3.61 2.18 2.30 3.72 2.63 2.07 2.66 2.69 2.82 2.72
121d 23.95 23.99 23.80 24.05 22.84 23.65 24.10 23.94 23.96 23.93
127d 27.60 28.80 28.45 28.89 28.88 28.93 29.27 29.16 29.12 29.12
129d 37.58 40.23 39.92 39.03 39.52 39.90 40.04 40.15 40.20 40.24
166d 15.04 16.60 13.97 14.93 14.91 15.49 15.47 15.62 15.67 15.67
195d 2.74 3.73 2.80 2.63 2.77 2.77 2.63 2.69 2.72 2.73
1d30 11.27 10.01 10.71 9.31 10.26 10.12 10.40 10.75 10.53 10.59
1d63 15.51 12.83 7.08 12.56 12.07 11.24 12.10 12.29 12.34 12.39
1d64 14.98 14.11 14.26 14.03 14.86 14.24 14.51 14.57 14.59 14.58
1d86 27.37 25.53 24.50 25.88 25.04 25.57 25.39 25.44 25.50 25.54
1dne 22.26 22.73 22.32 22.92 22.48 22.62 22.58 22.74 22.83 22.81
1eel 16.71 17.06 14.94 14.82 14.77 14.60 15.08 14.85 15.15 15.07
1fmq 12.35 13.40 14.28 14.72 15.27 15.09 15.30 15.36 15.36 15.37
1fms 27.08 26.14 25.17 24.52 25.41 25.93 25.82 25.75 25.71 25.74
1jtl 11.62 10.99 11.80 11.47 11.30 11.28 11.37 11.28 11.41 11.45
1lex 13.47 10.37 9.79 9.44 8.74 9.74 9.81 9.70 9.70 9.70
1prp 11.30 11.93 10.78 10.88 11.01 11.55 11.55 11.49 11.61 11.61
227d 6.28 4.79 5.96 3.79 5.47 5.16 5.80 5.75 5.46 5.58
261d 1.91 3.00 1.75 1.55 2.60 2.79 2.97 2.76 2.80 2.85
264d 33.64 32.35 31.57 30.83 32.09 31.97 32.07 32.20 32.31 32.34
289d 15.32 15.71 17.94 16.70 16.57 16.21 16.22 16.56 16.59 16.56
298d 11.65 15.94 14.81 15.89 14.87 14.88 15.38 15.45 15.50 15.41
2dbe 3.48 5.06 3.49 6.14 5.51 5.77 5.76 5.88 5.68 5.81
302d 23.28 25.22 24.91 25.49 24.95 25.00 24.87 25.29 25.17 25.19
311d 11.76 3.36 7.15 9.72 11.12 8.17 8.98 9.34 9.30 9.32
328d 14.25 16.21 17.38 17.85 16.79 17.14 17.84 17.68 17.54 17.54
360d 54.41 54.72 56.63 54.59 55.38 54.56 55.44 55.80 55.61 55.57
Barnase-barstar 1b27 86.80 83.08 95.40 82.48 87.05 89.40 87.35 87.96 86.96 87.05
1b2s 67.80 66.33 68.81 71.75 70.03 71.47 72.32 71.93 72.25 72.12
1b2u 85.97 76.39 74.78 78.29 75.29 77.35 77.15 78.38 78.87 78.57
1b3s 48.41 56.58 49.61 46.02 49.87 48.17 53.44 49.38 49.07 49.25
1x1u 61.75 66.86 74.53 75.07 77.56 76.56 75.06 76.41 76.06 75.95
1x1w 90.62 87.91 99.13 93.67 94.65 93.55 95.53 95.32 95.47 95.30
1x1x 115.79 110.40 110.45 112.19 113.51 114.45 115.30 114.65 114.62 114.65
1x1y 67.27 88.13 89.80 90.39 87.87 87.24 88.54 88.91 89.20 89.21
2za4 74.13 70.86 70.64 69.80 72.45 73.22 73.26 74.18 74.00 74.35
RNA-peptide 1a1t* 62.24 58.24 61.71 61.89 62.94 63.18 62.88 62.75 62.95 63.00
1a4t* 72.37 72.44 69.76 69.94 71.19 72.46 72.41 72.39 72.24 72.27
1biv* 41.80 40.73 42.07 44.90 45.66 44.70 44.69 44.75 44.86 44.76
1exy* 178.36 178.17 178.16 176.29 178.70 176.91 177.52 177.50 177.70 177.36
1g70 133.22 131.38 132.83 132.75 132.83 133.85 133.94 134.37 134.34 133.53
1hji 46.78 46.06 49.80 50.70 51.51 51.26 51.21 51.42 51.17 51.23
1i9f -19.78 -22.55 -22.49 -19.44 -19.31 -19.20 -19.18 -19.18 -19.20 -19.22
1mnb 126.65 129.00 127.74 126.95 127.80 127.82 128.30 128.15 128.15 128.20
1nyb -14.63 -13.07 -13.62 -12.58 -11.16 -13.04 -12.79 -12.45 -12.41 -12.61
1qfq 18.09 19.84 16.64 20.52 21.19 20.03 22.60 20.66 20.19 20.32
1ull* -53.38 -58.11 -54.20 -53.61 -51.66 -53.28 -52.52 -52.76 -52.66 -52.75
1zbn* 216.31 214.29 215.60 214.96 214.84 216.05 215.70 215.95 215.94 215.74
2a9x 385.99 384.41 385.18 385.36 385.05 385.20 385.36 385.36 385.43 385.44
484d* 129.72 129.65 133.42 132.09 131.34 132.03 132.79 133.20 133.23 133.38
* Results are significantly different (>50 kcal/mol) from those in Ref. 15
figures for barnase-barstar and RNA-peptide complexes can be referred to Figs. S1 and S2 in the
Supporting Information. Based on these figures, our solver can rank the binding free energy for
DNA-drug complexes at grid spacing of 0.6Å, barnase-barstar complexes at grid spacing of 0.6Å,
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Figure 5: Binding electrostatic energy for DNA-drug complexes with grid sizes from 0.2Å to
1.1Å. The markers and PDBIDs are as follows yellow circle : 102d, magenta circle : 109d, cyan
circle : 121d, green circle : 127d, red circle : 129d, blue circle : 166d, black circle : 195d, yellow
diamond : 1d30, magenta diamond : 1d63, cyan diamond : 1d64, green diamond : 1d86, red
diamond : 1dne, blue diamond : 1eel, black diamond : 1fmq, yellow square : 1fms, magenta
square : 1jtl, cyan square : 1lex, green square : 1prp, red square : 227d, blue square : 261d, black
square : 264d, yellow triangle: 289d, magenta triangle: 298d, cyan triangle: 2dbe, green triangle:
302d, red triangle: 311d, blue triangle: 328d, black triangle: 360d.
Figure 6: Averaged absolute error of the binding free energies for all the 51 complexes with mesh
size refinements from 1.1Å to 0.2Å.
and RNA-peptide complexes at significantly coarse grid spacing of 1.1Å. To further assess the
reliable estimates of binding energy of our MIBPB solver, we consider the absolute difference
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Figure 7: Binding energies of two complexes PDB IDs: 360d (marked by circle) and 1hji (marked
by square) at 30 different grid positions.
between results computed at a coarser grid spacing and the finest grid spacing defined by
δ∆∆Gel =
∣∣∆∆Gel,h−∆∆Gel,h=0.2∣∣ . (4)
Figure 6 plots the averaged absolute errors, δ∆∆Gel, i.e., the average of absolute errors defined
in Eq. (??) over all 51 complexes, at different mesh sizes. It is seen that even the use of grid
spacing of 0.7Å still delivers an averaged binding calculation error under 1 kcal/mol for this set of
complexes. Therefore, we can draw a conclusion that the common use of grid size being 0.5Å is
still adequate for predicting the binding energy free without producing a misleading result.
Grid positioning error is another feature to validate the robustness and accuracy of a PB solver.
To examine such numerical error for our MIBPB solver, we consider two protein complexes with
PDBIDs: 360d and 1hji. To estimate the standard deviation, σbd in ∆∆Gel, we randomly generate
29 grid positions around the initial origin with the amplitude of the random seed being ±0.5h,
where h = 0.5 Å is the grid spacing. Then ∆∆Gel is evaluated at all of the 30 grid positions.
Figure 7 plots electrostatic binding energies at 30 distinct samples of grid positions, including
the original one marked by Sample 0 on the graph. The σbd values of complexes 360d and 1hji
are found to be 0.18 and 0.21, respectively. These results indicate that the MIBPB solver is not
15
sensitive to grid position.
Note that in Table 3, some binding energies obtained in our calculations, all from RNA-peptide
complexes, differ significantly from those reported in Ref.,15 i.e., more than 50 kcal/mol at the
finest grid spacing, under the same parametrization and data inputs. However, overall, our results
have a good agreement with those in Ref.15 with R2 = 0.9135 for RNA-peptide complexes. To
further support our calculations, we have employed PBSA, Delphi, and APBS for electrostatic
energy calculations at the grid size of 0.2 Å. We note that results obtained from these solvers are
in excellent agreements, i.e., R2 > 0.98, with ours. The electrostatic energies calculated by PBSA,
Delphi, and APBS solvers are listed in Table S2 of Supporting Information.
4 Concluding remarks
Poisson-Boltzmann (PB) theory is an established model for biomolecular electrostatic analysis
and has been widely used in electrostatic solvation ∆Gel and binding energy ∆∆Gel estimations.
However, doubt has been cast on the validity of the commonly used grid spacing of 0.5 Å for
producing converged estimates of ∆∆Gel due to the unacceptable errors observed in the calcula-
tion using the solvent excluded surface (SES) and the adaptive Cartesian grid (ACG) finite differ-
ence PB equation solver.15 Three sets of biomolecular complexes, namely, DNA-drug complexes,
barnase-barstar complexes, and RNA-peptide complexes, are employed in the study. The discrep-
ancies between results obtained from different surface definitions were also utilized to support the
general pessimism for the PB methodology.
In this work, we employ the MIBPB software21,32 to estimate electrostatic solvation free en-
ergy, ∆Gel, and binding free electrostatic energy, ∆∆Gel, for the three sets of biomolecular com-
plexes used in Ref.15 The popular SES is adopted in the present work. In our ∆Gel estimation, the
averaged relative absolute error computed at a relatively coarse grid size of 1.1Å against the finest
grid size of 0.2 Å over 153 studied biomolecules is less than 0.31%. The same error obtained at
the grid size of 1.0Å is less than 0.2%. These results indicate the reliability of using the MIBPB
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solver at the grid spacing of 1.0Å or even 1.1Å for electrostatic solvation analysis. The robustness
and accuracy of MIBPB solver for estimates of ∆Gel have been reported for 24 proteins in the
literature.21,32 This characteristics has been confirmed again in the present work for DNA-drug
complexes, barnase-barstar complexes, and RNA-peptide complexes.
The well-converged ∆Gel produced by our solver enables a promising performance in predict-
ing ∆∆Gel at a coarse grid spacing. Indeed, numerical estimates of ∆∆Gel in the current work
reveals that ∆∆Gel obtained at a 1.1Å grid spacing mostly differ by less than 10 kcal/mol from
that achieved by using a 0.2Å grid spacing. Moreover, MIBPB solver conducted at grid size of
0.6Å perfectly produces a well-converged ∆∆Gel, and qualitatively ranks the complexes in term
of their binding free energies. Therefore, the current results support an opinion that the widely
used grid size of 0.5Å can give reliable and accurate enough predictions of both electrostatic free
energy39,40 and binding free energy.
To develop highly accurate, robust and reliable PB solvers for biomolecular electrostatics, it is
crucial to validate one’s numerical methods by appropriate norms and against realistic problems.
We emphasize that as an elliptic interface problem, it is important to measure the convergence of
PB solvers in the L∞ norm, or maximum absolute error, because integral norms, such as L1 and
L2, are insensitive to the performance of numerical methods near the interface. Additionally, the
convergence should be tested by solving the PB equation, rather than by calculating the solvation
free energy. Finally, validation should be carried out by using the SESs of proteins, rather than
smooth surfaces, such as a sphere.
Supporting Information Available
Electrostatic free energies calculated by different solvers, namely MIBPB, DELPHI, PBSA and
APBS; Coulombic binding energies; binding energy plots for barnase-barstar and RNA-peptide
complexes (filename: jctc_si_bdenergy.pdf).
This material is available free of charge via the Internet at http://pubs.acs.org/.
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